{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:20:00Z","timestamp":1780474800002,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01343-2","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:28:24Z","timestamp":1767025704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-center experience comparing glass and resin microspheres in lobar Y-90 SIRT for early- to intermediate-stage hepatocellular carcinoma"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-6000","authenticated-orcid":false,"given":"Xinlin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Matthijs","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs C.","family":"Bloemsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinoud P. H.","family":"Bokkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Mazuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"van Sluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles N.","family":"Stormezand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten W.","family":"Nijkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon J. S.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1343_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.21037\/hbsn-23-504","volume":"13","author":"P Vigneron","year":"2024","unstructured":"Vigneron P, Franze MS, Chalaye J, Tacher V, Sessa A, Luciani A, et al. Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review. Hepatobiliary Surg Nutr. 2024;13:974\u201390. https:\/\/doi.org\/10.21037\/hbsn-23-504.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1343_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-Fabrega J, Burrel M, Garcia-Criado A, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76:681\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018.","journal-title":"J Hepatol"},{"key":"1343_CR4","doi-asserted-by":"publisher","unstructured":"Yu Q, Khanjyan M, Fidelman N, Pillai A. Contemporary applications of Y90 for the treatment of hepatocellular carcinoma. Hepatol Commun. 2023;7. https:\/\/doi.org\/10.1097\/HC9.0000000000000288.","DOI":"10.1097\/HC9.0000000000000288"},{"key":"1343_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2967\/jnumed.116.184713","volume":"58","author":"A Van Der Gucht","year":"2017","unstructured":"Van Der Gucht A, Jreige M, Denys A, Blanc-Durand P, Boubaker A, Pomoni A, et al. Resin versus glass microspheres for (90)Y transarterial radioembolization: comparing survival in unresectable hepatocellular carcinoma using pretreatment partition model dosimetry. J Nucl Med. 2017;58:1334\u201340. https:\/\/doi.org\/10.2967\/jnumed.116.184713.","journal-title":"J Nucl Med"},{"key":"1343_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","volume":"34","author":"A Villalobos","year":"2023","unstructured":"Villalobos A, Arndt L, Cheng B, Dabbous H, Loya M, Majdalany B, et al. Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres. J Vasc Interv Radiol. 2023;34:1226\u201334. https:\/\/doi.org\/10.1016\/j.jvir.2023.02.030.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/MNM.0000000000001224","volume":"41","author":"TA Labeur","year":"2020","unstructured":"Labeur TA, Cieslak KP, Van Gulik TM, Takkenberg RB, van der Velden S, Lam M, et al. The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT\/CT for selective internal radiation therapy in hepatocellular carcinoma. Nucl Med Commun. 2020;41:740\u20139. https:\/\/doi.org\/10.1097\/MNM.0000000000001224.","journal-title":"Nucl Med Commun"},{"key":"1343_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jvir.2023.03.020","volume":"34","author":"H Briody","year":"2023","unstructured":"Briody H, Duong D, Yeoh SW, Hodgson R, Yong TL, Hannah A, et al. Radioembolization for treatment of hepatocellular carcinoma: current evidence and patterns of utilization. J Vasc Interv Radiol. 2023;34:1200\u201313. https:\/\/doi.org\/10.1016\/j.jvir.2023.03.020.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17\u201329. https:\/\/doi.org\/10.1016\/S2468-1253(20)30290-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1343_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00270-019-02404-5","volume":"43","author":"L Cardarelli-Leite","year":"2020","unstructured":"Cardarelli-Leite L, Chung J, Klass D, Marquez V, Chou F, Ho S, et al. Ablative transarterial radioembolization improves survival in patients with HCC and portal vein tumor thrombus. Cardiovasc Intervent Radiol. 2020;43:411\u201322. https:\/\/doi.org\/10.1007\/s00270-019-02404-5.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1343_CR11","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.2147\/OTT.S137519","volume":"10","author":"C Meyer","year":"2017","unstructured":"Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, et al. Yttrium-90 radioembolization of unresectable hepatocellular carcinoma - a single center experience. Onco Targets Ther. 2017;10:4773\u201385. https:\/\/doi.org\/10.2147\/OTT.S137519.","journal-title":"Onco Targets Ther"},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/HP.0000000000000631","volume":"112","author":"T James","year":"2017","unstructured":"James T, Hill J, Fahrbach T, Collins Z. Differences in radiation activity between glass and resin 90Y microspheres in treating unresectable hepatic cancer. Health Phys. 2017;112:300\u20134. https:\/\/doi.org\/10.1097\/HP.0000000000000631.","journal-title":"Health Phys"},{"key":"1343_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jvir.2016.01.147","volume":"27","author":"DM Biederman","year":"2016","unstructured":"Biederman DM, Titano JJ, Tabori NE, Pierobon ES, Alshebeeb K, Schwartz M, et al. Outcomes of radioembolization in the treatment of hepatocellular carcinoma with portal vein invasion: resin versus glass microspheres. J Vasc Interv Radiol. 2016;27:812\u2013e212. https:\/\/doi.org\/10.1016\/j.jvir.2016.01.147.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.21037\/jgo.2016.03.09","volume":"7","author":"SM Srinivas","year":"2016","unstructured":"Srinivas SM, Nasr EC, Kunam VK, Bullen JA, Purysko AS. Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases. J Gastrointest Oncol. 2016;7:530\u20139. https:\/\/doi.org\/10.21037\/jgo.2016.03.09.","journal-title":"J Gastrointest Oncol"},{"key":"1343_CR15","doi-asserted-by":"publisher","unstructured":"Teo JY, Allen JC Jr., Ng DC, Choo SP, Tai DW, Chang JP, et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. HPB (Oxford). 2016;18:7\u201312. https:\/\/doi.org\/10.1016\/j.hpb.2015.07.002.","DOI":"10.1016\/j.hpb.2015.07.002"},{"key":"1343_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1245\/s10434-009-0454-0","volume":"16","author":"RC Gaba","year":"2009","unstructured":"Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF, et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol. 2009;16:1587\u201396. https:\/\/doi.org\/10.1245\/s10434-009-0454-0.","journal-title":"Ann Surg Oncol"},{"key":"1343_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jvir.2024.03.005","volume":"35","author":"Q Yu","year":"2024","unstructured":"Yu Q, Wang Y, Ungchusri E, Pillai A, Liao CY, Fung J, et al. Modified radiation lobectomy strategy of radioembolization for Right-Sided unresectable primary liver tumors. J Vasc Interv Radiol. 2024;35:989\u201397. https:\/\/doi.org\/10.1016\/j.jvir.2024.03.005. e2.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"key":"1343_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13550-022-00879-x","volume":"12","author":"EB Veenstra","year":"2022","unstructured":"Veenstra EB, Ruiter SJS, de Haas RJ, Bokkers RPH, de Jong KP, Noordzij W. Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC. EJNMMI Res. 2022;12:9. https:\/\/doi.org\/10.1186\/s13550-022-00879-x.","journal-title":"EJNMMI Res"},{"key":"1343_CR20","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022;49:1682\u201399. https:\/\/doi.org\/10.1007\/s00259-021-05600-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1343_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jvir.2010.10.029","volume":"22","author":"R Salem","year":"2011","unstructured":"Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, et al. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol. 2011;22:265\u201378. https:\/\/doi.org\/10.1016\/j.jvir.2010.10.029.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251\u201378. https:\/\/doi.org\/10.1097\/01.RVI.0000233785.75257.9A.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR23","first-page":"s37","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:s37\u201361.","journal-title":"J Nucl Med"},{"key":"1343_CR24","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","volume":"48","author":"H Levillain","year":"2021","unstructured":"Levillain H, Bagni O, Deroose CM, Dieudonne A, Gnesin S, Grosser OS, et al. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging. 2021;48:1570\u201384. https:\/\/doi.org\/10.1007\/s00259-020-05163-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1343_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00259-015-3068-8","volume":"42","author":"C Chiesa","year":"2015","unstructured":"Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, et al. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Eur J Nucl Med Mol Imaging. 2015;42:1718\u201338. https:\/\/doi.org\/10.1007\/s00259-015-3068-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1343_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"key":"1343_CR27","unstructured":"Services USDoHaH. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017."},{"key":"1343_CR28","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1007\/s00330-023-10203-3","volume":"34","author":"Q Yu","year":"2024","unstructured":"Yu Q, Ungchusri E, Pillai A, Liao CY, Baker T, Fung J, et al. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma. Eur Radiol. 2024;34:2374\u201383. https:\/\/doi.org\/10.1007\/s00330-023-10203-3.","journal-title":"Eur Radiol"},{"key":"1343_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","volume":"151","author":"R Salem","year":"2016","unstructured":"Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, et al. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2016;151:1155\u2013e632. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.029.","journal-title":"Gastroenterology"},{"key":"1343_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.crad.2013.09.009","volume":"69","author":"JM Theysohn","year":"2014","unstructured":"Theysohn JM, Ertle J, Muller S, Schlaak JF, Nensa F, Sipilae S, et al. Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma. Clin Radiol. 2014;69:172\u20138. https:\/\/doi.org\/10.1016\/j.crad.2013.09.009.","journal-title":"Clin Radiol"},{"key":"1343_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jso.24269","volume":"114","author":"RJ Lewandowski","year":"2016","unstructured":"Lewandowski RJ, Donahue L, Chokechanachaisakul A, Kulik L, Mouli S, Caicedo J, et al. 90 Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. J Surg Oncol. 2016;114:99\u2013105. https:\/\/doi.org\/10.1002\/jso.24269.","journal-title":"J Surg Oncol"},{"key":"1343_CR32","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00270-024-03726-9","volume":"47","author":"GM Kim","year":"2024","unstructured":"Kim GM, Kim DY, Won JY, Moon S, Kim SU, Kim BK. Outcome of transarterial radioembolization in the treatment of hepatocellular carcinoma: glass versus resin microsphere. Cardiovasc Intervent Radiol. 2024;47:1210\u201321. https:\/\/doi.org\/10.1007\/s00270-024-03726-9.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1343_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jvir.2015.02.022","volume":"26","author":"SR Jernigan","year":"2015","unstructured":"Jernigan SR, Osborne JA, Mirek CJ, Buckner G. Selective internal radiation therapy: quantifying distal penetration and distribution of resin and glass microspheres in a surrogate arterial model. J Vasc Interv Radiol. 2015;26:897-904 e2. https:\/\/doi.org\/10.1016\/j.jvir.2015.02.022.","journal-title":"J Vasc Interv Radiol"},{"key":"1343_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","volume":"50","author":"R Salem","year":"2023","unstructured":"Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, et al. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2023;50:328\u201343. https:\/\/doi.org\/10.1007\/s00259-022-05956-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1343_CR35","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00270-022-03215-x","volume":"45","author":"E Garin","year":"2022","unstructured":"Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Trans-arterial radioembolization dosimetry in 2022. Cardiovasc Intervent Radiol. 2022;45:1608\u201321. https:\/\/doi.org\/10.1007\/s00270-022-03215-x.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1343_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2967\/jnumed.113.126839","volume":"55","author":"S Walrand","year":"2014","unstructured":"Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F. The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med. 2014;55:135\u201340. https:\/\/doi.org\/10.2967\/jnumed.113.126839.","journal-title":"J Nucl Med"},{"key":"1343_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00259-015-3157-8","volume":"43","author":"E Garin","year":"2016","unstructured":"Garin E, Rolland Y, Laffont S, Edeline J. Clinical impact of (99m)Tc-MAA SPECT\/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43:559\u201375. https:\/\/doi.org\/10.1007\/s00259-015-3157-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1343_CR38","doi-asserted-by":"publisher","unstructured":"d\u2019Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres used in liver radioembolization: from conception to clinical effects. Molecules. 2021;26. https:\/\/doi.org\/10.3390\/molecules26133966.","DOI":"10.3390\/molecules26133966"},{"key":"1343_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040959","author":"C Romano","year":"2022","unstructured":"Romano C, Mazzaglia S, Maccauro M, Spreafico C, Gabutti A, Maffi G, et al. Radioembolization of hepatocellular carcinoma with (90)Y glass microspheres: no advantage of voxel dosimetry with respect to mean dose in dose-response analysis with two radiological methods. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14040959.","journal-title":"Cancers"},{"key":"1343_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijrobp.2010.08.015","volume":"82","author":"WY Lau","year":"2012","unstructured":"Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2012;82:401\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.08.015.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1343_CR41","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.22.03452-5","author":"MN Braat","year":"2022","unstructured":"Braat MN, Braat AJ, Lam MG. Toxicity comparison of yttrium-90 resin and glass microspheres radioembolization. Q J Nucl Med Mol Imaging. 2022. https:\/\/doi.org\/10.23736\/S1824-4785.22.03452-5.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1343_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1148\/radiol.2020191606","volume":"296","author":"AL Hermann","year":"2020","unstructured":"Hermann AL, Dieudonne A, Ronot M, Sanchez M, Pereira H, Chatellier G, et al. Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with (90)Y in the SARAH study. Radiology. 2020;296:673\u201384. https:\/\/doi.org\/10.1148\/radiol.2020191606.","journal-title":"Radiology"},{"key":"1343_CR43","doi-asserted-by":"publisher","unstructured":"Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol. 2014;4. https:\/\/doi.org\/10.3389\/fonc.2014.00210.","DOI":"10.3389\/fonc.2014.00210"},{"key":"1343_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2022.998793","volume":"2","author":"A Dieudonne","year":"2022","unstructured":"Dieudonne A, Sanchez-Garcia M, Bando-Delaunay A, Lebtahi R. Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres. Front Nucl Med. 2022;2:998793. https:\/\/doi.org\/10.3389\/fnume.2022.998793.","journal-title":"Front Nucl Med"},{"key":"1343_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13550-025-01240-8","volume":"15","author":"A van den Brekel","year":"2025","unstructured":"van den Brekel A, Snoeijink TJ, de Meijer VE, Boswinkel M, de Jong KP, Roosen J, et al. Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation. EJNMMI Res. 2025;15:49. https:\/\/doi.org\/10.1186\/s13550-025-01240-8.","journal-title":"EJNMMI Res"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01343-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:28:25Z","timestamp":1767025705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01343-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01343-2","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the Dutch Medical Research Involving Human Subject Act, the local medical ethical committee exempted approval without additional procedures in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. No additional informed consent was required. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}